These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28839258)

  • 61. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
    Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
    EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.
    Feng J; Zhang Y; She X; Sun Y; Fan L; Ren X; Fu H; Liu C; Li P; Zhao C; Liu Q; Liu Q; Li G; Wu M
    Oncogene; 2019 Jan; 38(1):103-119. PubMed ID: 30082910
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
    Yi L; Tong L; Li T; Hai L; Abeysekera IR; Tao Z; Ma H; Liu P; Xie Y; Li J; Yuan F; Yu S; Yang X
    Mol Med Rep; 2018 Jul; 18(1):741-748. PubMed ID: 29767255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
    Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
    Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypoxia differentially upregulates the expression of embryonic, fetal and adult hemoglobin in human glioblastoma cells.
    Emara M; Turner AR; Allalunis-Turner J
    Int J Oncol; 2014 Mar; 44(3):950-8. PubMed ID: 24379112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.
    Pistollato F; Abbadi S; Rampazzo E; Persano L; Della Puppa A; Frasson C; Sarto E; Scienza R; D'avella D; Basso G
    Stem Cells; 2010 May; 28(5):851-62. PubMed ID: 20309962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
    Sa JK; Chang N; Lee HW; Cho HJ; Ceccarelli M; Cerulo L; Yin J; Kim SS; Caruso FP; Lee M; Kim D; Oh YT; Lee Y; Her NG; Min B; Kim HJ; Jeong DE; Kim HM; Kim H; Chung S; Woo HG; Lee J; Kong DS; Seol HJ; Lee JI; Kim J; Park WY; Wang Q; Sulman EP; Heimberger AB; Lim M; Park JB; Iavarone A; Verhaak RGW; Nam DH
    Genome Biol; 2020 Aug; 21(1):216. PubMed ID: 32847614
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.
    Wang L; Wei Y; Yan Y; Wang H; Yang J; Zheng Z; Zha J; Bo P; Tang Y; Guo X; Chen W; Zhu X; Ge L
    Oncol Rep; 2018 Mar; 39(3):951-966. PubMed ID: 29286141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Experimental studies on correlation between nucleolus spindle-related protein 1 and the malignant progression and prognosis of human glioblastoma multiforme].
    Xue YP; Ji XY; Yang L; Liu HR; Sheng YJ; Dai XX; Xi YJ; Liu JC; Shi J; Xie T; Zhang YS; Ma JW; Dong J
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(5):340-345. PubMed ID: 29429243
    [No Abstract]   [Full Text] [Related]  

  • 74. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
    Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
    PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
    Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
    PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
    Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
    Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
    Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
    PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.